Putting the award page together from the records…
Putting the award page together from the records…
Research Triangle Institute received this contract from Ofc of Acquisition and Grants Management, Centers for Medicare and Medicaid Services: $57.47M obligated so far for support- professional: other. It runs to 2027-02-19, or to 2029-12-08 if every option is exercised.
Key facts · data as of Oct 21, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 21, 2026.
Cite this page: SpendQuery, Award 75FCMC24F0128, data as of Oct 21, 2026, https://spendquery.com/award?id=CONT_AWD_75FCMC24F0128_7530_GS00F354CA_4732
Research Triangle Institute: all federal awards · Department of Health and Human Services: spending · Ofc of Acquisition and Grants Management: what it buys · The follow-on: recompete brief
DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS)
Up for re-bid: ends 2027-02-19. Recompete brief → · Request for Information - CMS' Qualified Independent Contractor (QIC) Program ↗
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
18 subawards totaling $12.45M (21.7% of what was obligated), as Research Triangle Institute reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| National Opinion Research Center | $4.69M | 1 | IL | 2025-04-28 | 2025-04-28 |
| Bland & Associates PC | $2.05M | 1 | NE | 2025-02-13 | 2025-02-13 |
| Evaluate Limited | $1.59M | 2 | 2025-03-14 | 2026-01-22 | |
| Telligen, Inc | $1.02M | 1 | IA | 2025-02-19 | 2025-02-19 |
| Caerus US 1 Inc. | $869.0K | 1 | NY | 2026-03-19 | 2026-03-19 |
| The Aci Group, Inc. | $781.8K | 2 | MD | 2025-06-12 | 2026-02-13 |
| Ipd Analytics, LLC | $649.0K | 2 | FL | 2025-06-12 | 2026-03-30 |
| Clarivate Analytics (US) LLC | $349.8K | 1 | MI | 2025-05-22 | 2025-05-22 |
| SS Holdings Group LLC | $204.8K | 3 | NJ | 2025-03-03 | 2026-02-25 |
| SSR Health LLC | $159.0K | 2 | NJ | 2025-04-03 | 2026-04-07 |
| HMP Communications LLC | $63.6K | 1 | PA | 2025-05-13 | 2025-05-13 |
| Sago Solutions LLC | $37.1K | 1 | TX | 2025-06-17 | 2025-06-17 |
| Date | To | Amount | For |
|---|---|---|---|
| 2025-04-28 | National Opinion Research Center | $4.69M | 3-312-0219681 INITIAL AWARD |
| 2025-02-13 | Bland & Associates PC | $2.05M | SUBCONTRACT 2-312-0219681 INITIAL AWARD |
| 2025-02-19 | Telligen, Inc | $1.02M | SUBCONTRACT 1-312-0219681 INITIAL AWARD |
| 2026-03-19 | Caerus US 1 Inc. | $869.0K | PO RTI1006152 |
| 2026-01-22 | Evaluate Limited | $869.0K | PO RTI1004587 |
| 2025-03-14 | Evaluate Limited | $716.6K | PO C000634958 |
| 2026-02-13 | The Aci Group, Inc. | $500.0K | PO RTI1005183 |
| 2025-05-22 | Clarivate Analytics (US) LLC | $349.8K | PO C000635450 |
| 2026-03-30 | Ipd Analytics, LLC | $339.8K | PO RTI1006402 |
| 2025-06-12 | Ipd Analytics, LLC | $309.2K | PO C000635526 |
| 2025-06-12 | The Aci Group, Inc. | $281.8K | PO C000635524 |
| 2026-04-07 | SSR Health LLC | $87.0K | PO RTI1006666 |
| 2026-02-25 | SS Holdings Group LLC | $86.2K | PO RTI1005526 |
| 2025-04-03 | SSR Health LLC | $72.0K | PO C000635169 |
| 2025-05-13 | HMP Communications LLC | $63.6K | PO C000635367 |
| 2025-03-03 | SS Holdings Group LLC | $61.0K | PO C000634888 |
| 2025-10-24 | SS Holdings Group LLC | $57.6K | PO RTI1002807 |
| 2025-06-17 | Sago Solutions LLC | $37.1K | PO C000635563 |
14 actions since 2024-07-17. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-16 | P00013 | Supplemental agreement (work within scope) | $0 | DAPS IRA |
| 2026-06-29 | P00012 | Supplemental agreement (work within scope) | $0 | EO 14398 |
| 2026-02-12 | P00011 | Option exercised | $27.69M | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2025-11-03 | P00010 | Supplemental agreement (work within scope) | $0 | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2025-09-29 | P00009 | Administrative change | $0 | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2025-07-08 | P00008 | Supplemental agreement (work within scope) | $0 | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2025-06-16 | P00007 | Supplemental agreement (work within scope) | $300.0K | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2025-04-03 | P00006 | Supplemental agreement (work within scope) | $0 | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2025-03-12 | P00005 | Administrative change | $0 | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2025-03-06 | P00004 | Option exercised | $1.13M | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2025-01-31 | P00003 | Administrative change | $0 | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2024-12-05 | P00002 | Administrative change | $0 | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2024-08-01 | P00001 | Administrative change | $0 | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
| 2024-07-17 | 0 | $28.35M | DATA ANALYTICS AND PROGRAM SUPPORT FOR IMPLEMENTATION AND OPERATIONALIZATION OF MEDICARE PRESCRIPTION DRUG PROVISIONS OF THE INFLATION REDUCTION ACT (DAPS) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-21). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗